Trial: 202101053

Parallel Phase III Randomized Trials For High Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict- RT*) *Prostate RNA Expression/Decipher To Individualize Concurrent Therapy with Radiation

Phase

III

Principal Investigator

Michalski, Jeff

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov